Ligand Pharmaceuticals Incorporated (LGND): Share Price, Stock Analysis, Annual Report | Value Research Get Ligand Pharmaceuticals Incorporated (LGND)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Biotechnology & Pharma Research

Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ: LGND

  • Market Capitalisation info

    $1,812 Mln


  • 12 Month Earnings info

    $24 Mln

  • Price to Earnings info

    73.00

$106.79

As on 17-Aug-2022 13:37 EDT

up-down-arrow $-0.77-0.72%

  • Prev Close info

    $107.56

  • Day's Openinfo

    $105.69

  • Today's Highinfo

    $107.93

  • Today's Lowinfo

    $105.53

  • Today's Volumeinfo

    32,756

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Ligand Pharmaceuticals (LGND)
-30.86 12.97 23.13 -0.43 4.00 -3.49 20.55
S&P BSE Sensex
3.44 12.09 13.75 8.42 17.29 13.66 13.06
S&P Small-Cap 600
-8.42 12.89 8.31 -4.42 11.76 8.97 10.87
As on 17-Aug-2022
2021
2020
2019
2018
2017
2016
2015
Ligand Pharmaceuticals (LGND)
55.31 -4.64 -23.15 -0.89 34.76 -6.28 103.76
S&P Small-Cap 600
25.27 9.57 20.86 -9.70 11.73 24.74 -3.36
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95 -5.03

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        CEO & Exec. Director

        Mr. John L. Higgins

        Pres & COO

        Mr. Matthew W. Foehr

        Headquarters

        EmeryVille, CA
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $1,811.69 Mln

        • Revenue (TTM) info

          $267.68 Mln

        • Earnings (TTM) info

          $24.10 Mln

        • Cash info

          $204.00 Mln

        • Total Debt info

          $195.20 Mln

        • Insider's Holding

          5.50%

        • Liquidity info

          Low

        • 52 Week range info

          $72.57 - 169.98

        • Shares outstanding info

          16,861,300

        • 10 Years Aggregate:

          CFO: $537.82 Mln

          EBITDA: $1,433.57 Mln

          Net Profit: $1,118.37 Mln

        About The Company

        • Business

          Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide.

        • IPO Date

          18-Nov-1992

        • CEO & Exec. Director

          Mr. John L. Higgins

        • Pres & COO

          Mr. Matthew W. Foehr

        • Listing info

          NASDAQ: LGND

        • Country

          United States

        • Headquarters info

          EmeryVille, CA

        • Website info

          https://www.ligand.com